99.40
-4.16 (-4.02%)
-4.16 (-4.02%)
Upgrade to Real-Time
Regular Market
| Volume | 349,695 |
|
|||||
| News | (4) | ||||||
| Day High | 104.215 | Low High |
|||||
| Day Low | 98.85 | ||||||
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Level 1 Starter
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company Ltd | BHVN | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| -4.16 | -4.02% | 99.40 | 13:12:43 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 103.80 | 98.85 | 104.215 | 103.56 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 7,050 | 349,695 | $ 101.35 | $ 35,440,683 | - | 62.57 - 151.51 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 13:13:17 | 25 | $ 99.57 | USD |
Period:
Draw Mode:
Biohaven Pharmaceutical Holding Company Ltd Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 6.51B | 65.50M | 58.13M | $ 63.63M | $ - | -13.06 | -7.50 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | -4.37k | 10.00% |
Biohaven Pharmaceutical News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BHVN Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 115.38 | 116.63 | 98.85 | 108.87 | 589,843 | -15.98 | -13.85% |
| 1 Month | 146.51 | 147.72 | 98.85 | 117.11 | 691,761 | -47.11 | -32.15% |
| 3 Months | 137.43 | 151.51 | 98.85 | 127.76 | 462,335 | -38.03 | -27.67% |
| 6 Months | 90.75 | 151.51 | 90.75 | 117.43 | 562,135 | 8.65 | 9.53% |
| 1 Year | 90.07 | 151.51 | 62.57 | 98.13 | 570,849 | 9.33 | 10.36% |
| 3 Years | 40.56 | 151.51 | 26.56 | 64.99 | 679,190 | 58.84 | 145.07% |
| 5 Years | 20.00 | 151.51 | 16.5001 | 57.48 | 564,401 | 79.40 | 397.0% |
Biohaven Pharmaceutical Description
| Biohaven Pharmaceutical Holding Co Ltd is a clinical-stage biopharmaceutical company. It has a portfolio of late-stage product candidates targeting neurological diseases, including rare disorders. The company product candidates are based on multiple mechanisms-calcitonin gene-related peptide receptor antagonists, glutamate modulators and myeloperoxidase inhibitor. Its pipeline products include BHV-3100, BHV5000, BHV5500, among others. |
